Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
Sponsor: Sonoma Biotherapeutics, Inc.
Summary
This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans. Increasing dose levels will be given after the safety at lower dose levels is shown.
Official title: A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Activity of Single Ascending Doses of SBT777101 in Subjects With Rheumatoid Arthritis
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
24
Start Date
2024-03-06
Completion Date
2026-03
Last Updated
2024-11-27
Healthy Volunteers
No
Conditions
Interventions
SBT777101
Experimental treatment
Locations (8)
Mayo Clinic
Scottsdale, Arizona, United States
UCSF Medical Center
San Francisco, California, United States
Stanford Medical Center
Stanford, California, United States
University of Colorado
Aurora, Colorado, United States
Northwestern University
Chicago, Illinois, United States
Tufts University
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States